SDP Japan Secures Funding
SDP Japan, headquartered in Shibuya, Tokyo, recently announced the successful completion of a fundraising round totaling approximately 4.5 billion yen (around $40 million) through various financial channels, including a Series D third-party allocation of shares, existing shareholder stock transfers, bank loans, and asset financing. This funding round saw participation from seven investors, led by JP Investment.
Background and Future Outlook for Funding
In light of Japan's aging population, the medical industry is projected to experience sustainable growth. Specifically, in the orthopedic and cardiovascular sectors where SDP Japan focuses its efforts, surgical procedures are increasing at an annual rate of 5-8% (according to Yano Research Institute), with demand expected to continue until around 2050.
However, the surgical medical field faces structural challenges. This domain requires advanced technology and expertise, yet many physicians struggle to obtain adequate surgical environments and support systems. Furthermore, patients often face randomness in meeting trusted doctors, indicating a pressing need to bridge the information gap in healthcare.
SDP Japan aims to transform medical service delivery by creating a supportive environment where doctors can focus on their techniques and patients can find suitable treatments. Over the years, the company has established a unique position in providing integrated support in medical delivery, including marketing, facility production, and management support, primarily in urban areas. This has enabled the expansion of surgical-focused medical institutions.
The recent funding is intended to reinforce this growth foundation further and expand a next-generation healthcare model nationwide. SDP Japan is committed to reconstructing medical infrastructure, including in regional cities, deepening cooperation with stakeholders from various fields to achieve sustainable healthcare solutions. The company strives to become a driving force for advancing Japan's medical industry, leveraging its startup speed and execution capabilities.
Comments from President Matoi Nagayou
Matoi Nagayou, the President of SDP Japan, expressed gratitude for the support received during this substantial fundraising effort. He highlighted the company's journey in building a system that supports an environment for doctors to exhibit their skills and ensures patients can access optimal treatments. Currently, SDP Japan has assisted over 3,000 surgeries annually.
Looking ahead, the company plans to extend its initiatives to regional cities, striving for a nationwide healthcare model without regional disparities. He emphasized that the key driving force behind this growth remains ‘people’ and expressed eagerness to meet individuals passionate about making a difference in the healthcare sector.
Strengthening Recruitment
To accelerate the support of new medical institutions, SDP Japan is enhancing its recruitment efforts in various areas:
- - Patient engagement marketing (both digital and physical spaces)
- - Business development (medical equipment procurement, physician support, business revitalization)
- - On-site support roles (including assignments to hospitals with administrative experience)
For more details, please visit the company's recruitment website:
SDP Japan Recruiting
About SDP Japan
Founded in January 2014, SDP Japan operates under the mission of “Filling the world with excitement and joy through advanced surgeries.” The company supports the national expansion of specialized medical institutions for surgical procedures focusing on orthopedics and cardiovascular diseases. Its services encompass patient engagement marketing, surgical material supply, procurement of real estate and advanced medical equipment, as well as back-office operations, providing innovative solutions to stakeholders involved in surgical procedures. Since its inception, thanks to its strategic position in Tokyo's metropolitan area, SDP Japan has produced seven healthcare institutions, assisting roughly 14,000 surgeries, particularly excelling in arrhythmias, artificial joints, and spinal specialties.
Summary of Fundraising
- - Total Raised: Approximately 4.5 billion yen
Participating Institutions (in no particular order)
- JP Investment (Lead Investor)
- T&D Innovation Fund (Managed by Spiral Innovation Partners)
- Sumitomo Mitsui Trust Bank
- Japan Co-Investment Fund No. 4
- Toda Corporation
- Eight Roads Ventures Japan
- GLOBIS Capital Partners
- - Loans and Leases:
- - Resona Bank
- - Shizuoka Bank
- - SBI Shinsei Bank
- - Other institutions